Janney Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-205,826
| Closed | -$11.2M | – | 217 |
|
|
2022
Q2 | $11.2M | Sell |
205,826
-244
| -0.1% | -$13.5K | 0.9% | 41 |
|
|
2022
Q1 | $11.2M | Buy |
206,070
+1,800
| +0.9% | +$97.8K | 0.8% | 49 |
|
|
2021
Q4 | $11.3M | Sell |
204,270
-4,486
| -2% | -$233K | 0.73% | 56 |
|
|
2021
Q3 | $9.97M | Sell |
208,756
-4,346
| -2% | -$218K | 0.67% | 63 |
|
|
2021
Q2 | $10.6M | Sell |
213,102
-1,557
| -0.7% | -$74.8K | 0.68% | 64 |
|
|
2021
Q1 | $9.58M | Buy |
214,659
+8,426
| +4% | +$382K | 0.63% | 68 |
|
|
2020
Q4 | $9.49M | Sell |
206,233
-25,386
| -11% | -$1.17M | 0.66% | 61 |
|
|
2020
Q3 | $10.9M | Sell |
231,619
-17,755
| -7% | -$890K | 0.74% | 51 |
|
|
2020
Q2 | $12.7M | Sell |
249,374
-15,782
| -6% | -$810K | 0.88% | 38 |
|
|
2020
Q1 | $12.6M | Sell |
265,156
-37,454
| -12% | -$2M | 0.96% | 33 |
|
|
2019
Q4 | $17.8M | Sell |
302,610
-21,524
| -7% | -$1.2M | 0.96% | 35 |
|
|
2019
Q3 | $17.3M | Sell |
324,134
-21,412
| -6% | -$1.1M | 0.96% | 38 |
|
|
2019
Q2 | $17.3M | Sell |
345,546
-12,092
| -3% | -$607K | 0.94% | 42 |
|
|
2019
Q1 | $18.7M | Sell |
357,638
-3,176
| -0.9% | -$159K | 0.98% | 39 |
|
|
2018
Q4 | $17.2M | Sell |
360,814
-14,112
| -4% | -$695K | 0.93% | 39 |
|
|
2018
Q3 | $18.8M | Sell |
374,926
-8,946
| -2% | -$455K | 0.82% | 43 |
|
|
2018
Q2 | $19.3M | Sell |
383,872
-2,989
| -0.8% | -$151K | 0.85% | 40 |
|
|
2018
Q1 | $18.9M | Buy |
386,861
+22,505
| +6% | +$1.05M | 0.82% | 43 |
|
|
2017
Q4 | $16.2M | Sell |
364,356
-26,000
| -7% | -$1.2M | 0.69% | 58 |
|
|
2017
Q3 | $19.8M | Sell |
390,356
-8,591
| -2% | -$436K | 0.85% | 41 |
|
|
2017
Q2 | $21.5M | Sell |
398,947
-8,006
| -2% | -$427K | 1.01% | 30 |
|
|
2017
Q1 | $21.4M | Buy |
406,953
+2,828
| +0.7% | +$143K | 0.99% | 31 |
|
|
2016
Q4 | $19.5M | Sell |
404,125
-34,301
| -8% | -$1.69M | 0.89% | 37 |
|
|
2016
Q3 | $23.6M | Buy |
438,426
+75,348
| +21% | +$4.13M | 1.07% | 33 |
|
|
2016
Q2 | $19.7M | Sell |
363,078
-73
| -0% | -$3.85K | 1.04% | 40 |
|
|
2016
Q1 | $18.4M | Buy |
363,151
+11,321
| +3% | +$564K | 0.99% | 43 |
|
|
2015
Q4 | $17.7M | Sell |
351,830
-11,823
| -3% | -$603K | 0.78% | 53 |
|
|
2015
Q3 | $17.5M | Buy |
+363,653
| New | +$18.9M | 0.79% | 52 |
|
|
2015
Q2 | – | Sell |
-364,833
| Closed | -$21M | – | 108 |
|
|
2015
Q1 | $21M | Buy |
364,833
+24,478
| +7% | +$1.4M | 0.7% | 47 |
|
|
2014
Q4 | $18.2M | Buy |
340,355
+84,821
| +33% | +$4.75M | 1.05% | 38 |
|
|
2014
Q3 | $14.7M | Buy |
255,534
+15,616
| +7% | +$957K | 0.89% | 50 |
|
|
2014
Q2 | $16M | Buy |
239,918
+16,796
| +8% | +$1.14M | 0.97% | 45 |
|
|
2014
Q1 | $14.9M | Buy |
223,122
+18,397
| +9% | +$1.24M | 0.99% | 43 |
|
|
2013
Q4 | $13.7M | Buy |
204,725
+22,614
| +12% | +$1.47M | 1.01% | 38 |
|
|
2013
Q3 | $11.4M | Buy |
182,111
+16,613
| +10% | +$1.07M | 0.94% | 38 |
|
|
2013
Q2 | $10.3M | Buy |
+165,498
| New | +$10.5M | 1.02% | 39 |
|
Other funds holding GSK
Janney Capital Management's GSK Position: Q3 2022 in Review
Janney Capital Management sold out of GSK (GSK) in Q3 2022, closing a stake of 205,826 shares — an estimated $11.2M sold.
Janney Capital Management first reported a position in GSK in Q2 2013 and held it in 36 quarters. The position peaked at $23.6M in Q3 2016. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.
- Janney Capital Management reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
- Janney Capital Management sold 205,826 GSK shares in Q3 2022, an estimated $11.2M.
- Janney Capital Management first reported a position in GSK in Q2 2013 and held it in 36 quarters.
- Janney Capital Management's GSK position peaked at $23.6M in Q3 2016.
- 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.
Based on Janney Capital Management's 13F filing for Q3 2022, filed 25 Oct 2022.